STAAR Surgical Company stock is down -4.15% since 30 days ago. The next earnings date is Feb 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40.62% of the previous 31 December’s closed higher than November. In the last 5 Unusual Options Trades, there were 4 PUTs, 1 CALL. 0% of analysts rate it a buy.
|Date & Time||Expiration Date||Strike Price||Trade Type||Size||Open Interest|
|01 Nov 15:43||15 Mar, 2024||45.00||107|
|02 Nov 15:54||17 Nov, 2023||42.50||160|
|06 Nov 20:02||17 Nov, 2023||40.00||979|
|01 Dec 17:18||15 Dec, 2023||30.00||191|
|05 Dec 18:25||15 Mar, 2024||25.00||20|
STAAR Surgical Company designs, develops, manufactures, markets, and sells implantable lenses for the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems.